Klass Russell Kevin 4
4 · Zomedica Corp. · Filed Nov 12, 2024
Insider Transaction Report
Form 4
Klass Russell Kevin
Sr Vice President, Sales
Transactions
- Purchase
Common Stock, without par value
2024-11-11$0.12/sh+210,200$25,224→ 1,210,250 total - Purchase
Common Stock, without par value
2024-11-11$0.12/sh+289,800$35,066→ 1,500,050 total